Information de reference pour ce titreAccession Number: | 00002849-201108010-00015.
|
Author: | Jung, Carole 1,+; Gene, Gemma G. 1,+; Tomas, Marta 2,+; Plata, Cristina 1; Selent, Jana 3; Pastor, Manuel 3; Fandos, Cesar 1; Senti, Mariano 1,2; Lucas, Gavin 2; Elosua, Roberto 2,4; Valverde, Miguel A. 1,*
|
Institution: | (1)Laboratory of Molecular Physiology and Channelopathies, Universitat Pompeu Fabra, Parc de Recerca Biomedica de Barcelona, Room 343, C/ Dr. Aiguader 88, Barcelona 08003, Spain (2)Cardiovascular Epidemiology and Genetics Research Group, IMIM Institut de Recerca Hospital del Mar, Barcelona 08003, Spain (3)Biomedical Informatics Program, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain (4)Centro de Investigacion Biomedica en Red in Epidemiology and Public Health, Barcelona, Spain
|
Title: | |
Source: | Cardiovascular Research. 91(3):465-471, August 1, 2011.
|
Abstract: | Aims: The TRPC4 non-selective cation channel is widely expressed in the endothelium, where it generates Ca2+ signals that participate in the endothelium-mediated vasodilatory response. This study sought to identify single-nucleotide polymorphisms (SNPs) in the TRPC4 gene that are associated with myocardial infarction (MI).
Methods and results: Our candidate-gene association studies identified a missense SNP (TRPC4-I957V) associated with a reduced risk of MI in diabetic patients [odds ratio (OR) = 0.61; confidence interval (CI), 0.40-0.95, P= 0.02]. TRPC4 was also associated with MI in the Wellcome Trust Case-Control Consortium's genome-wide data: an intronic SNP (rs7319926) within the same linkage disequilibrium block as TRPC4-I957V showed an OR of 0.86 (CI, 0.81-0.94; P =10-4). Functional studies of the missense SNP were carried out in HEK293 and CHO cells expressing wild-type or mutant channels. Patch-clamp studies and measurement of intracellular [Ca2+] in response to muscarinic agonists and direct G-protein activation showed increased channel activity in TRPC4-I957V-transfected cells compared with TRPC4-WT. Site-directed mutagenesis and molecular modelling of TRPC4-I957V suggested that the gain of function was due to the presence of a less bulky Val-957. This permits a firmer interaction between the TRPC4 and the catalytic site of the tyrosine kinase that phosphorylates TRPC4 at Tyr-959 and facilitates channel insertion into the plasma membrane.
Conclusion: We provide evidence for the association of a TRPC4 SNP with MI in population-based genetic studies. The higher Ca2+ signals generated by TRPC4-I957V may ultimately facilitate the generation of endothelium- and nitric oxide-dependent vasorelaxation, thereby explaining its protective effect at the vasculature.
(C) Copyright Oxford University Press 2011.
|
Author Keywords: | Myocardial infarction; TRP ion channels; Calcium; Genetics of cardiovascular diseases; Gene polymorphisms.
|
References: | 1. Montell C. The TRP superfamily of cation channels Sci STKE. 2005;2005:re3
2. Inoue R, Jensen LJ, Shi J, Morita H, Nishida M, Honda A, et al. Transient receptor potential channels in cardiovascular function and disease Circ Res. 2006;99:119-131
3. Firth AL, Remillard CV, Yuan JX. TRP channels in hypertension Biochim Biophys Acta. 2007;1772:895-906
4. Thilo F, Baumunk D, Krause H, Schrader M, Miller K, Loddenkemper C, et al. Transient receptor potential canonical type 3 channels and blood pressure in humans J Hypertens. 2009;27:1217-1223
5. Smedlund K, Vazquez G. Involvement of native TRPC3 proteins in ATP-dependent expression of VCAM-1 and monocyte adherence in coronary artery endothelial cells Arterioscler Thromb Vasc Biol. 2008;28:2049-2055
6. Pozsgai G, Bodkin JV, Graepel R, Bevan S, Andersson DA, Brain SD. Evidence for the pathophysiological relevance of TRPA1 receptors in the cardiovascular system in vivo Cardiovasc Res. 2010;87:760-768
7. Yu Y, Keller SH, Remillard CV, Safrina O, Nicholson A, Zhang SL, et al. A functional single-nucleotide polymorphism in the TRPC6 gene promoter associated with idiopathic pulmonary arterial hypertension Circulation. 2009;119:2313-2322
8. Tian W, Fu Y, Garcia-Elias A, Fernandez-Fernandez JM, Vicente R, Kramer PL, et al. A loss-of-function nonsynonymous polymorphism in the osmoregulatory TRPV4 gene is associated with human hyponatremia Proc Natl Acad Sci USA. 2009;106:14034-14039
9. Cantero-Recasens G, Gonzalez JR, Fandos C, Duran-Tauleria E, Smit LA, Kauffmann F, et al. Loss of function of transient receptor potential vanilloid 1 (TRPV1) genetic variant is associated with lower risk of active childhood asthma J Biol Chem. 2010;285:27532-27535
10. Yip H, Chan WY, Leung PC, Kwan HY, Liu C, Huang Y, et al. Expression of TRPC homologs in endothelial cells and smooth muscle layers of human arteries Histochem Cell Biol. 2004;122:553-561
11. Tiruppathi C, Freichel M, Vogel SM, Paria BC, Mehta D, Flockerzi V, et al. Impairment of store-operated Ca2+ entry in TRPC4(-/-) mice interferes with increase in lung microvascular permeability Circ Res. 2002;91:70-76
12. Zhang S, Remillard CV, Fantozzi I, Yuan JX. ATP-induced mitogenesis is mediated by cyclic AMP response element-binding protein-enhanced TRPC4 expression and activity in human pulmonary artery smooth muscle cells Am J Physiol Cell Physiol. 2004;287:C1192-C1201
13. Freichel M, Suh SH, Pfeifer A, Schweig U, Trost C, Weissgerber P, et al. Lack of an endothelial store-operated Ca2+ current impairs agonist-dependent vasorelaxation in TRP4-/- mice Nat Cell Biol. 2001;3:121-127
14. Schaefer M, Plant TD, Obukhov AG, Hofmann T, Gudermann T, Schultz G. Receptor-mediated regulation of the nonselective cation channels TRPC4 and TRPC5 J Biol Chem. 2000;275:17517-17526
15. Odell AF, Scott JL, Van Helden DF. Epidermal growth factor induces tyrosine phosphorylation, membrane insertion, and activation of transient receptor potential channel 4 J Biol Chem. 2005;280:37974-37987
16. Otsuguro K, Tang J, Tang Y, Xiao R, Freichel M, Tsvilovskyy V, et al. Isoform-specific inhibition of TRPC4 channel by phosphatidylinositol 4,5-bisphosphate J Biol Chem. 2008;283:10026-10036
17. Jaggar JH, Porter VA, Lederer WJ, Nelson MT. Calcium sparks in smooth muscle Am J Physiol Cell Physiol. 2000;278:C235-C256
18. McDonald TF, Pelzer S, Trautwein W, Pelzer DJ. Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells Physiol Rev. 1994;74:365-507
19. Thorneloe KS, Nelson MT. Ion channels in smooth muscle: regulators of intracellular calcium and contractility Can J Physiol Pharmacol. 2005;83:215-242
20. Dick GM, Tune JD. Role of potassium channels in coronary vasodilation Exp Biol Med (Maywood). 2010;235:10-22
21. Fernandez-Fernandez JM, Tomas M, Vazquez E, Orio P, Latorre R, Senti M, et al. Gain-of-function mutation in the KCNMB1 potassium channel subunit is associated with low prevalence of diastolic hypertension J Clin Invest. 2004;113:1032-1039
22. Tomas M, Vazquez E, Fernandez-Fernandez JM, Subirana I, Plata C, Heras M, et al. Genetic variation in the KCNMA1 potassium channel alpha subunit as risk factor for severe essential hypertension and myocardial infarction J Hypertens. 2008;26:2147-2153
23. Senti M, Fernandez-Fernandez JM, Tomas M, Vazquez E, Elosua R, Marrugat J, et al. Protective effect of the KCNMB1 E65K genetic polymorphism against diastolic hypertension in aging women and its relevance to cardiovascular risk Circ Res. 2005;97:1360-1365
24. Beitelshees AL, Gong Y, Wang D, Schork NJ, Cooper-Dehoff RM, Langaee TY, et al. KCNMB1 genotype influences response to verapamil SR and adverse outcomes in the INternational VErapamil SR/Trandolapril STudy (INVEST) Pharmacogenet Genomics. 2007;17:719-729
25. Beitelshees AL, Navare H, Wang D, Gong Y, Wessel J, Moss JI, et al. CACNA1C gene polymorphisms, cardiovascular disease outcomes, and treatment response Circ Cardiovasc Genet. 2009;2:362-370
26. Kohler R. Single-nucleotide polymorphisms in vascular Ca2+-activated K+-channel genes and cardiovascular disease Pflugers Arch. 2010;460:343-351
27. Nilius B, Droogmans G. Ion channels and their functional role in vascular endothelium Physiol Rev. 2001;81:1415-1459
28. Serban DN, Nilius B, Vanhoutte PM. The endothelial saga: the past, the present, the future Pflugers Arch. 2010;459:787-792
29. Nora JJ, Lortscher RH, Spangler RD, Nora AH, Kimberling WJ. Genetic-epidemiologic study of early-onset ischemic heart disease Circulation. 1980;61:503-508
30. Musunuru K, Kathiresan S. Genetics of coronary artery disease Annu Rev Genomics Hum Genet. 2010;11:91-108
31. Musunuru K, Strong A, Frank-Kamenetsky M, Lee NE, Ahfeldt T, Sachs KV, et al. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus Nature. 2010;466:714-719
32. Masia R, Pena A, Marrugat J, Sala J, Vila J, Pavesi M, et al. High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence. REGICOR Investigators J Epidemiol Community Health. 1998;52:707-715
33. Fernandes J, Lorenzo IM, Andrade YN, Garcia-Elias A, Serra SA, Fernandez-Fernandez JM, et al. IP3 sensitizes TRPV4 channel to the mechano- and osmotransducing messenger 5'-6'-epoxyeicosatrienoic acid J Cell Biol. 2008;181:143-155
34. Abdullaev IF, Bisaillon JM, Potier M, Gonzalez JC, Motiani RK, Trebak M. Stim1 and Orai1 mediate CRAC currents and store-operated calcium entry important for endothelial cell proliferation Circ Res. 2008;103:1289-1299
35. Tsai W, Morielli AD, Peralta EG. The m1 muscarinic acetylcholine receptor transactivates the EGF receptor to modulate ion channel activity EMBO J. 1997;16:4597-4605
36. Blom N, Gammeltoft S, Brunak S. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites J Mol Biol. 1999;294:1351-1362
37. Zecchin HG, Priviero FB, Souza CT, Zecchin KG, Prada PO, Carvalheira JB, et al. Defective insulin and acetylcholine induction of endothelial cell-nitric oxide synthase through insulin receptor substrate/Akt signaling pathway in aorta of obese rats Diabetes. 2007;56:1014-1024
38. Huang PL. eNOS, metabolic syndrome and cardiovascular disease Trends Endocrinol Metab. 2009;20:295-302
39. Kearney MT, Duncan ER, Kahn M, Wheatcroft SB. Insulin resistance and endothelial cell dysfunction: studies in mammalian models Exp Physiol. 2008;93:158-163
|
Language: | English.
|
Document Type: | ORIGINAL ARTICLES.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 0008-6363
|
NLM Journal Code: | cor, 0077427
|
DOI Number: | https://dx.doi.org/10.1093/cvr/c...- ouverture dans une nouvelle fenêtre
|
Annotation(s) | |
|
|